Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: VIB Vermögen AG: Annual General Meeting of VIB Vermögen AG resolves to increase the dividend for the eleventh time in a row
DGAP-News: VIB Vermögen AG: Annual General Meeting of VIB Vermögen AG resolves to increase the dividend for the eleventh time in a row
DGAP-News: VIB Vermögen AG: Annual General Meeting of VIB Vermögen AG resolves to increase the dividend for the eleventh time in a row
DGAP-News: Northern Data announces new Block.one backed customer
DGAP-News: Northern Data announces new Block.one backed customer
DGAP-News: Northern Data announces new Block.one backed customer
DGAP-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners sells 500,000 shares in Flatex AG; Proceeds from the sale of more than EUR 20 million
DGAP-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners sells 500,000 shares in Flatex AG; Proceeds from the sale of more than EUR 20 million
DGAP-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners sells 500,000 shares in Flatex AG; Proceeds from the sale of more than EUR 20 million
DGAP-News: Northern Data: SBI becomes new strategic shareholder
DGAP-News: Northern Data: SBI becomes new strategic shareholder
DGAP-News: Northern Data: SBI becomes new strategic shareholder
DGAP-Adhoc: Northern Data decides on partial cash settlement of the convertible bond
DGAP-Adhoc: Northern Data decides on partial cash settlement of the convertible bond
DGAP-Adhoc: Northern Data decides on partial cash settlement of the convertible bond
DGAP-News: PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
DGAP-News: PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
DGAP-News: PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
DGAP-Adhoc: PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVO) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
DGAP-Adhoc: PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVO) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
DGAP-Adhoc: PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVO) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
DGAP-News: Flash Update: Delivery Hero order numbers close to double amidst COVID-19 pandemic: https://www.deliveryhero.com/newsroom/downloads/
DGAP-News: Flash Update: Delivery Hero order numbers close to double amidst COVID-19 pandemic
DGAP-News: Flash Update: Delivery Hero order numbers close to double amidst COVID-19 pandemic
DGAP-News: Vonovia SE: Vonovia Successfully Places Two Unsecured Bonds : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23633/Vonovia_Logo.svg.png
DGAP-News: Vonovia SE: Vonovia Successfully Places Two Unsecured Bonds
DGAP-News: Vonovia SE: Vonovia Successfully Places Two Unsecured Bonds
Form 8.3 - The Vanguard Group, Inc.: Pollen Street Secured Lending plc
Form 8.3 - The Vanguard Group, Inc.: Pollen Street Secured Lending plc
Form 8.3 - The Vanguard Group, Inc.: Pollen Street Secured Lending plc
Form 8.3 - The Vanguard Group, Inc.: Georgia Capital plc: https://mms.businesswire.com/media/20200227005467/en/776283/5/Georgia_Capital_logo.jpg
Form 8.3 - The Vanguard Group, Inc.: Georgia Capital plc
Form 8.3 - The Vanguard Group, Inc.: Georgia Capital plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
AEW UK REIT plc: Investor Presentation
AEW UK REIT plc: Investor Presentation
AEW UK REIT plc: Investor Presentation
Edison Investment Research Limited: Edison issues outlook on Telix Pharmaceuticals (TLX)
Edison Investment Research Limited: Edison issues outlook on Telix Pharmaceuticals (TLX)
Edison Investment Research Limited: Edison issues outlook on Telix Pharmaceuticals (TLX)
DGAP-News: Grand City Properties publishes the subscription price and subscription ratio
DGAP-News: Grand City Properties publishes the subscription price and subscription ratio
DGAP-News: Grand City Properties publishes the subscription price and subscription ratio
PJSC RusHydro: Results of the Board of Directors Meeting on June 29, 2020
PJSC RusHydro: Results of the Board of Directors Meeting on June 29, 2020
PJSC RusHydro: Results of the Board of Directors Meeting on June 29, 2020
DGAP-Adhoc: JENOPTIK AG: Jenoptik accelerates profitable growth with acquisition of TRIOPTICS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24060/Jenoptik-Logo.svg.png
DGAP-Adhoc: JENOPTIK AG: Jenoptik accelerates profitable growth with acquisition of TRIOPTICS
DGAP-Adhoc: JENOPTIK AG: Jenoptik accelerates profitable growth with acquisition of TRIOPTICS
Sartorius Stedim Biotech SA: Half-year report of the liquidity contract with the stockbroker company Gilbert Dupont
Sartorius Stedim Biotech SA: Half-year report of the liquidity contract with the stockbroker company Gilbert Dupont
Sartorius Stedim Biotech SA: Half-year report of the liquidity contract with the stockbroker company Gilbert Dupont
DGAP-News: Workload of paragon Plants Almost at Previous Year's Level
DGAP-News: Workload of paragon Plants Almost at Previous Year's Level
DGAP-News: Workload of paragon Plants Almost at Previous Year's Level
DGAP-News: Annual general meeting of Berentzen-Gruppe Aktiengesellschaft: Dividend of EUR 0.28 per share agreed
DGAP-News: Annual general meeting of Berentzen-Gruppe Aktiengesellschaft: Dividend of EUR 0.28 per share agreed
DGAP-News: Annual general meeting of Berentzen-Gruppe Aktiengesellschaft: Dividend of EUR 0.28 per share agreed
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Form 8.3 - Baader Bank AG: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Form 8.3 - Baader Bank AG: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Form 8.3 - Baader Bank AG: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Fuller, Smith & Turner PLC: Total Voting Rights
Fuller, Smith & Turner PLC: Total Voting Rights
Fuller, Smith & Turner PLC: Total Voting Rights
ANDREY BOUGROV TO BECOME NORNICKEL'S SENIOR VICE PRESIDENT FOR ENVIRONMENTAL PROTECTION
ANDREY BOUGROV TO BECOME NORNICKEL'S SENIOR VICE PRESIDENT FOR ENVIRONMENTAL PROTECTION
ANDREY BOUGROV TO BECOME NORNICKEL'S SENIOR VICE PRESIDENT FOR ENVIRONMENTAL PROTECTION